DE69733414D1 - Protein tyrosin-phosphatasen von hematopoietischen zellen - Google Patents

Protein tyrosin-phosphatasen von hematopoietischen zellen

Info

Publication number
DE69733414D1
DE69733414D1 DE69733414T DE69733414T DE69733414D1 DE 69733414 D1 DE69733414 D1 DE 69733414D1 DE 69733414 T DE69733414 T DE 69733414T DE 69733414 T DE69733414 T DE 69733414T DE 69733414 D1 DE69733414 D1 DE 69733414D1
Authority
DE
Germany
Prior art keywords
nucleic acid
ptp
protein tyrosine
tyrosine phosphatases
hscs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69733414T
Other languages
English (en)
Other versions
DE69733414T2 (de
Inventor
A Lasky
Jill Cheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE69733414D1 publication Critical patent/DE69733414D1/de
Application granted granted Critical
Publication of DE69733414T2 publication Critical patent/DE69733414T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DE69733414T 1996-03-22 1997-03-17 Protein tyrosin-phosphatasen von hematopoietischen zellen Expired - Fee Related DE69733414T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62052696A 1996-03-22 1996-03-22
US620526 1996-03-22
PCT/US1997/005278 WO1997035019A1 (en) 1996-03-22 1997-03-17 Protein tyrosine phosphatases of hematopoietic cells

Publications (2)

Publication Number Publication Date
DE69733414D1 true DE69733414D1 (de) 2005-07-07
DE69733414T2 DE69733414T2 (de) 2006-04-27

Family

ID=24486323

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69733414T Expired - Fee Related DE69733414T2 (de) 1996-03-22 1997-03-17 Protein tyrosin-phosphatasen von hematopoietischen zellen

Country Status (10)

Country Link
EP (1) EP0906433B1 (de)
JP (1) JP3496938B2 (de)
AT (1) ATE296891T1 (de)
AU (1) AU719909B2 (de)
CA (1) CA2246430C (de)
DE (1) DE69733414T2 (de)
IL (1) IL125939A (de)
MX (1) MXPA98007322A (de)
WO (1) WO1997035019A1 (de)
ZA (1) ZA972446B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0914452A2 (de) * 1996-06-17 1999-05-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Ptp-20,pcp-2bdp1, clk und sirp proteine und verwandte produkte
US7074589B1 (en) 1996-06-17 2006-07-11 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Nucleic acids encoding BDP-1
US6004791A (en) 1996-11-13 1999-12-21 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Protein tyrosine phosphatase PTP20 and related products and methods
US6541615B1 (en) 1996-11-15 2003-04-01 Max-Planck-Gellschaft Zur Foderung Der Wissenschaften E.V. SIRP proteins and uses thereof
US6797513B2 (en) 1996-12-19 2004-09-28 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Nucleic acid encoding CLK2 protein kinases
CA2220853A1 (en) * 1998-01-16 1999-07-16 Hsc Research And Development Limited Partnership Human lymphoid protein tyrosine phosphatases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627489B1 (de) * 1990-03-14 1998-09-02 Washington Research Foundation Methode und Zusammensetzungen zur Behandlung von bösartigen Entartungen, die in Zusammenhang mit einer Proteinkinase stehen

Also Published As

Publication number Publication date
AU719909B2 (en) 2000-05-18
CA2246430C (en) 2008-09-02
EP0906433B1 (de) 2005-06-01
ATE296891T1 (de) 2005-06-15
IL125939A0 (en) 1999-04-11
AU2348297A (en) 1997-10-10
EP0906433A1 (de) 1999-04-07
WO1997035019A1 (en) 1997-09-25
JP3496938B2 (ja) 2004-02-16
ZA972446B (en) 1998-09-21
JP2000507104A (ja) 2000-06-13
CA2246430A1 (en) 1997-09-25
DE69733414T2 (de) 2006-04-27
IL125939A (en) 2008-06-05
MXPA98007322A (es) 2004-08-24

Similar Documents

Publication Publication Date Title
Lomonte et al. A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo)
DE69735716D1 (de) Kappa/mu ähnliche proteintyrosinphosphatase, proteintyrosinphosphatase lambda
DK38189A (da) Hidtil ukendte fusionsproteiner indeholdende glutation-s-transferase
EA200000216A1 (ru) Белки, связывающие интерлейкин-18, их получение и применение
AR053063A2 (es) Proteina sustancialmente purificada y composicion farmaceutica que la comprende
BR9808545A (pt) ácido nucleico isolado, vetor de expressão, célula hospedeira, processos para produzir uma proteìna de ligação da osteoprotegerina, para detectar a presença de uma proteìna de ligação à osteoprotegerina em uma amostra biológica, para avaliar a capacidade de um composto candidato de ligar-se a uma proteìna de ligação da osteoprotegerina e de um composto de teste para aumentar ou reduzir a ligação da proteìna de ligação da osteoprotegerina a odar, para regular a expressão de uma proteìna de ligação da osteoprotegerina em um animal e para prevenir ou tratar de doença óssea em um mamìfero, polipeptìdeo, protéina de ligação da osteroprotegerina purificada e isolada, ou seu fragmento, análogo ou derivado, e, anticorpo ou seu fragmento
DE69838334D1 (de) Kdr, ein menschlicher tyrosin kinase rezeptor
Tedeschi et al. Purification and primary structure of a new bovine spermadhesin
HUP0002472A2 (hu) Izolált dendritikus sejtmembrán-fehérje gének
DK611386A (da) Recombinant humant fsh, fremgangsmaade til fremstilling deraf og vektorer og celler til anvendelse ved fremgangsmaaden
DE69834643D1 (de) Adipozyten-spezifische protein homologe
ES2173471T3 (es) Analisis para homocisteina y homocisteina desulfurasa a partir de tricomonas viginalis de protozoos.
Rasmussen et al. Two‐dimensional electrophoretic analysis of human breast carcinoma proteins: Mapping of proteins that bind to the SH3 domain of mixed lineage kinase MLK2
DE69733414D1 (de) Protein tyrosin-phosphatasen von hematopoietischen zellen
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
Kerjan et al. Mammalian prolyl-tRNA synthetase corresponds to the≈ 150 kDa subunit of the high-Mr aminoacyl-tRNA synthetase complex
ES2054743T3 (es) Muteina de beta-galactosidasa enzimaticamente inactiva e inmunologicamente activa.
Martin‐Pérez et al. Activation of ribosomal protein S6 phosphorylation during meiotic maturation of Xenopus laevis oocytes: in vitro ordered appearance of S6 phosphopeptides.
ATE273390T1 (de) Säugertier edg-7 rezeptor homologen
ATE472599T1 (de) Chemokin alpha-5
DE59712771D1 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
BR9910725A (pt) Indução de proteìnas e peptìdeos antibióticos por proteìnas lait/s cd14
Carden et al. Chemical cross-linking analyses of ox neurofilaments
Morgan et al. Complete covalent structure of human platelet factor 4
Niimi et al. Specific expression of annexin III in rat-small-hepatocytes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee